1. Working to overcome the global impact of neglected tropical diseases Documenting the achievement of elimination as a public health problem GPELF dossier template Preventive Chemotherapy and Transmission Control Unit Department of Control of Neglected Tropical Diseases World Health Organization

2. M&E WG subgroup 2 meeting, Aug 2014 Draft template presented and reviewed - to serve as a tool for national LF programmes to summarize minimal information needed to document LF elimination to standardize presentation of information to make review of dossiers easier –Provide complete information required for review process –Reduce clarifications needed by reviewers after submission of dossier

3. References 1999 WHO Guidelines for Certifying LF Elimination 2011 WHO TAS manual, Chapter 9 “Verifying the absence of transmission” 2012 WHO draft checklist for TAS planning and verification of interruption of LF transmission Dec 2013 M&E sub group on disease-specific indicators meeting on LF Endgame Issues

4. Process Draft narrative section and data tables developed ‘Pilot testing’ template in Philippines and Bangladesh Harmonizing with… –WHO TAS eligibility and reporting form –WHO Joint Reporting Form and PC Epidemiological Data Reporting Form To be auto-generated by the Integrated NTD Database

5. Format 1.Narrative –Word document –Overall description of the programme –A few key summary data tables 2.Data Annex –Excel file with 7 summary data tables –Line listing of IU data by topic

6. Structure SectionNarrativeData Annex 1General descriptionSheet 1. Population 2History of LFSheet 2. Mapping 3Interventions for interruption of transmission Sheet 3. MDA Sheet 4. Supplemental interventions 4Assessment of interventions for interruption of transmission Sheet 5. M&E 5SurveillanceSheet 6. Surveillance 6Special issues 7Morbidity management and disability prevention Sheet 7. Morbidity 8Bibliography 9Abbreviations

7. 1. General description 1.Overall geographic and economic features of the country Administrative levels table 2.Health system 3.LF programme overview Role of partners table 4.Regional context

8. 2. History of LF 1.Detailed description of pre-programme phase 2.Data used to classify implementation units as endemic or non-endemic –Map of endemicity

9. 3. Interventions for interruption of transmission 1.MDA (required) Implementation Reported overage summary table 2.Supplemental interventions Oncho MDA STH deworming Vector control Test and treat Environmental or economic improvements

10. 4. Assessment of interventions for interruption of transmission 1.Sentinel and spot-check sites (required) 2.Surveys for stopping MDA (required)

11. 5. Surveillance 1.Cross-sectional surveys, including post-MDA TAS (required) 2.Ongoing surveillance 3.Entomological monitoring (if available)

12. 6. Special issues 1.Special circumstances that have affected implementation or surveillance of the programme, including: –Stability or security –Migration –Mobile populations –Special population groups 2.Table with summary of investigations or surveillance in special population groups

13. 7. MMDP 1.Disease burden (required) Number of lymphoedema and hydrocele cases per IU o Toolkit contains menu of options for assessing disease burden (e.g. population-based surveys, leveraging current GPELF activities (MDA, coverage survey, community-based TAS), house-to-house line listing 2.Availability of MMDP services (required) Availability of at least one health facility in the IU known to have cases that provide MMDP services o Questionnaire to district NTD focal points 3.Quality of MMDP services (required) Number of facilities providing MMDP services surveyed for quality assessment o Toolkit contains a tool for direct facility inspection (subset of facilities within an IU with known burden)

14. Other sections 8. Bibliography Key articles and reports to be kept on file in national programme office 9. Abbreviations

15. Next steps Incorporate comments from meetings (Sept-Oct 2014) Final draft template circulated to ROs for comments (Oct 2014) Submit to STAG M&E Working Group (Oct 2014) Submit to STAG-NTD April 2015 as part of Elimination Process SOP for recommendation Distribute to WHO RO and CO for distribution to country programs (May 2015)